Biliary DyskinesiaSymptoms, Doctors, Treatments, Advances & More
Biliary Dyskinesia Overview
Learn About Biliary Dyskinesia
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Danbury Hospital
Stuart Sherman is a Radiologist practicing medicine in Danbury, Connecticut. Dr. Sherman is rated as an Elite provider by MediFind in the treatment of Biliary Dyskinesia. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Biliary Dyskinesia, Sphincter of Oddi Dysfunction, Pancreas Divisum, Endoscopy, and Lithotripsy.
Rayus/Foundation Radiology Group
Todd Blodgett is a Radiologist practicing medicine in Wexford, Pennsylvania. Dr. Blodgett is rated as a Distinguished provider by MediFind in the treatment of Biliary Dyskinesia. He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Visceromegaly, Diverticular Disease, and Emphysema. Dr. Blodgett is board certified in American Board Of Radiology.
Rayus/Foundation Radiology Group
Tim Miller is a Radiologist practicing medicine in Wexford, Pennsylvania. Dr. Miller is rated as a Distinguished provider by MediFind in the treatment of Biliary Dyskinesia. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Gallbladder Disease, Diverticular Disease, Visceromegaly, and Non-Alcoholic Fatty Liver Disease. Dr. Miller is board certified in American Board Of Radiology.
Summary: This open-label study will evaluate the effect of food on the bioavailability of a single dose of 4-MUST, tablets, 128 mg. Additionally, the study will assess the pharmacokinetics, safety, and tolerability of 4-MUST, tablets, 128 mg following both single and multiple oral dose administration.
Summary: The aim of the study is to evaluate the efficacy, safety, and tolerability of 4-MUST, 128 mg tablets compared to placebo in patients with chronic cholecystitis and biliary dyskinesia.